NYSE : TDOC
Teladoc Health, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 8.73 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.59B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.57B |
| Enterprise Value | 1.76B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 182.29M |
| Shares Outstanding | 182.29M |
| Shares Change (YoY) | +2.87% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 0.69% |
| Owned by Institutions (%) | 86.36% |
| Float | 181.04M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| Forward PS | 0.66 |
| PB Ratio | 1.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.92 |
| P/OCF Ratio | 5.78 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.70 |
| EV / EBITDA | 20.30 |
| EV / EBIT | n/a |
| EV / FCF | 6.63 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.87 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 10.45 |
| Debt / FCF | 3.95 |
| Interest Coverage | -6.50 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -11.52% |
| Return on Assets (ROA) | -2.93% |
| Return on Invested Capital (ROIC) | -3.47% |
| Return on Capital Employed (ROCE) | -9.73% |
| Weighted Average Cost of Capital (WACC) | 10.25% |
| Revenue Per Employee | $440,740 |
| Profits Per Employee | -$27,647 |
| Employee Count | 5,600 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 21.96 |
Taxes
| Measure | Value |
|---|
| Income Tax | -3.83M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.14 |
| 52-Week Price Change | -1.10% |
| 50-Day Moving Average | 6.28 |
| 200-Day Moving Average | 6.48 |
| Relative Strength Index (RSI) | 77.84 |
| Average Volume (20 Days) | 4,720,208 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 32.07M |
| Short Previous Month | 27.63M |
| Short % of Shares Out | 17.59% |
| Short % of Float | 17.71% |
| Short Ratio (days to cover) | 8.82 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.47B |
| Gross Profit | 1.69B |
| Operating Income | -132.33M |
| Pretax Income | -158.65M |
| Net Income | -154.82M |
| EBITDA | 85.54M |
| EBIT | -132.33M |
| Loss Per Share | -$0.86 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 849.91M |
| Total Debt | 1.04B |
| Net Cash | -185.24M |
| Net Cash Per Share | -$1.02 |
| Equity (Book Value) | 1.29B |
| Book Value Per Share | 7.10 |
| Working Capital | -189.49M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 268.38M |
| Capital Expenditures | -6.42M |
| Depreciation & Amortization | 217.87M |
| Net Borrowing | n/a |
| Free Cash Flow | 261.96M |
| FCF Per Share | $1.44 |
Margins
| Measure | Value |
|---|
| Gross Margin | 68.57% |
| Operating Margin | -5.36% |
| Pretax Margin | -6.43% |
| Profit Margin | -6.27% |
| EBITDA Margin | 3.47% |
| EBIT Margin | -5.36% |
| FCF Margin | 10.61% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.87% |
| Shareholder Yield | -2.87% |
| Earnings Yield | -9.97% |
| FCF Yield | 16.89% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.15 |
| Price Target Difference | -5.60% |
| Analyst Consensus | Hold |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | -2.16% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.21 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |